14 July 2026 at 9:16 am
Summary
The US FDA has approved an at-home starter dose for Eisai and Biogen's Alzheimer's drug, Leqembi, allowing patients to self-administer subcutaneous injections. This approval improves access to treatment and differentiates Leqembi from competitor Kisunla, which requires infusion-only administration.
FDA Approves Novel Pill for Significant Cholesterol Reduction in High-Risk Patients
17 Jul 2026, 1:25 pm · Science
FDA Approves Merck's Lipfendra, a Groundbreaking Oral Pill for Cholesterol Reduction
17 Jul 2026, 7:19 am · health
Drone Use Slashes TB Diagnosis Cost, Time in Telangana: ICMR
16 Jul 2026, 9:15 pm · Health
Woman Sells House to Fund Treatment for Aggressive Brain Cancer
17 Jul 2026, 3:29 pm · Health
NEET UG 2026 Result Declared: AIR 1 Aryan Gupta Credits Hard Work, Advises Aspirants
17 Jul 2026, 9:35 am · Health
Turn this story into an image post, carousel, video, audio reel, blog, and more — all from AI News Studio.
Pick a story, apply your brand template, and publish polished graphics to Facebook, Instagram, LinkedIn, and more — without opening a design tool.
Create Image PostDescribe the story, headline, colors, and style you want.
Try Prompt to PostCombine branded news graphics with narration — from your audio library, a live recording, or AI text-to-speech — and share as engaging short-form content.
Create Audio PostUpload your footage, apply a video template with baked-in headlines, add optional audio, and schedule posts across every connected social channel.
Create Video PostCombine several news items into a single swipeable carousel post — with a shared title, unified caption, and per-slide template content for maximum engagement.
Create CarouselUpload your media, craft the perfect caption with AI assistance, preview on every platform, and schedule posts for the exact moment your audience is online.
Schedule a PostTransform breaking news into long-form, SEO-optimized blog posts with AI writing, a rich text editor, featured images, and one-click social image post creation.
Create Blog PostTurn any news article into a professional anchor video with AI-generated presenters, natural voice narration, and lip-sync animation — no studio, no crew, no wait.
Learn moreFAQAbout the public News Studio news feed powered by NewsEngine.